Powell Industries: A Golden Buying Opportunity After Recent Pullback — Positive

POWL   Seeking Alpha — February 13, 2025

Powell Industries reported a 24.4% year-on-year revenue increase to $241.1 million in Q1 FY25, despite moderated growth in core markets like petrochemicals and oil and gas. Strong order activity across the end markets and benefits from robust backlog and expanded capacity should fuel topline growth in FY25. Anticipated volume growth and benefits from focus on operational improvements are expected to support margins in the quarters ahead.

image for news Powell Industries: A Golden Buying Opportunity After Recent Pullback

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=129305&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on Innovative Industrial Properties, Inc. (IIPR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129315&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=129317&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Electronic Arts Inc. ("Electronic Arts Inc.") (NASDAQ:EA) concerning possible violations of federal securities laws. On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company's prior expectations.

image for news Levi & Korsinsky Announces an Investigation on Behalf of Electronic Arts Inc. (EA) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=129316&wire=1 or contact Joseph E. Levi, Esq.

image for news Crocs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 24, 2025 to Discuss Your Rights - CROX

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=129308&wire=1 or contact Joseph E. Levi, Esq.

image for news Grocery Outlet Holding Corp. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - GO

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129306&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc. (NMRA)

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129319&wire=1 or contact Joseph E. Levi, Esq.

image for news NTLA LAWSUIT ALERT: Levi & Korsinsky Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129328&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129331&wire=1 or contact Joseph E.

image for news Lost Money on FTAI Aviation Ltd. (FTAI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Mullen Automotive Inc. Announces Reverse Stock Split Effective Feb. 18, 2025 — Neutral

MULN   GlobeNewsWire — February 13, 2025

BREA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announced today that it will effect a 1-for-60 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on Feb. 18, 2025, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the existing symbol MULN and will begin trading on a split-adjusted basis when the market opens on Feb. 18, 2025. The new CUSIP …

image for news Mullen Automotive Inc. Announces Reverse Stock Split Effective Feb. 18, 2025

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=129333&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders that Lost Money on Caribou Biosciences, Inc. (CRBU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129326&wire=1 or contact Joseph E. Levi, Esq.

image for news Nextracker Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 25, 2025 to Discuss Your Rights - NXT

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

image for news Harmonic Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HLIT

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129330&wire=1 or contact Joseph E. Levi, Esq.

image for news Pacira BioSciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=129320&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors Who Lost Money on Regeneron Pharmaceuticals, Inc. (REGN) Should Contact Levi & Korsinsky About Pending Class Action - REGN

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129321&wire=1 or contact Joseph E.

image for news February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - RIG

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results — Negative

JNJ   New York Post — February 13, 2025

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.

image for news Johnson & Johnson halts late-stage E.coli vaccine trial after poor results

Gilat's Q4 Earnings Surpass Estimates, Revenues Lag, Stock Tanks — Positive

GILT   Zacks Investment Research — February 13, 2025

GILT's fourth-quarter 2024 performance reflects expanding momentum in the defense and IFC sectors, backed by increasing deal wins.

image for news Gilat's Q4 Earnings Surpass Estimates, Revenues Lag, Stock Tanks